title: Prevalence and therapeutic significance of anti-interferon antibodies in hepatitis C virus/HIV-co-infected patients.
authors.forename: Belen
authors.initials: B
authors.lastname: Ramos
authors.forename: Julie
authors.initials: J
authors.lastname: Sheldon
authors.forename: Andres
authors.initials: A
authors.lastname: Ruiz-Sancho
authors.forename: Carlos
authors.initials: C
authors.lastname: Toro
authors.forename: Pilar
authors.initials: P
authors.lastname: Ríos
authors.forename: Vincent
authors.initials: V
authors.lastname: Soriano
mesh_terms: D000328:Adult; D000917:Antibody Formation; D000998:Antiviral Agents / Q000276:immunology; D005260:Female; D015658:HIV Infections / Q000150:complications*; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D017211:Treatment Failure
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b